AMLX vs REGN: Which Stock is Better?

Side-by-side comparison of Amylyx Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

AMLX

Amylyx Pharmaceuticals Inc

$14.22

REGN

Regeneron Pharmaceuticals Inc

$614.78

Key Metrics Comparison

MetricAMLXREGNWinner
Market Cap$1.58B$64.45BREGN
P/E RatioN/A15.02REGN
EPS (TTM)$N/A$40.94REGN
Revenue Growth-1.0%0.2%REGN
Gross Margin14420.3%43.9%AMLX

Analyze AMLX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMLX or REGN a better investment?

Comparing AMLX and REGN: Amylyx Pharmaceuticals Inc has a market cap of $1.58B while Regeneron Pharmaceuticals Inc has $64.45B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMLX and REGN?

AMLX (Amylyx Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMLX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AMLX or REGN?

REGN has higher revenue growth at 0.2% vs -1.0% for AMLX.

Which company is more profitable: AMLX or REGN?

Amylyx Pharmaceuticals Inc (AMLX) has higher gross margins at 14420.3% compared to 43.9% for REGN.

Which is the larger company: AMLX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $64.45B compared to $1.58B for AMLX.

Should I buy AMLX or REGN in 2026?

Both AMLX and REGN have investment merit. AMLX trades at $14.22 while REGN trades at $614.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMLX and REGN stock?

Key differences: Market Cap ($1.58B vs $64.45B), P/E Ratio (N/A vs 15.0x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (14420.3% vs 43.9%).

Popular Stock Comparisons